In the study by Isgaard et al. (1998), despite biochemical evidence of GH activity, no significant vascular or hemodynamic improvements were observed, suggesting potential resistance mechanisms in advanced HF cohorts [17]. This evidence concerns the gene GH1 and hydrops fetalis.